Home NDC 0093-8741 Mexiletine Hydrochloride
Product NDC 0093-8741
11-digit product format 000938741
Labeler code 0093
Product ID 0093-8741_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Mexiletine Hydrochloride
Dosage form CAPSULE
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA074377
Marketing category ANDA
Marketing start 1995-06-05
Substance MEXILETINE HYDROCHLORIDE
Active strength 250 mg/1
Pharmacologic classes Antiarrhythmic [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 0093-8741 UNFINISHED Active or certified unfinished drug listing 2026-08-17 unfinished package package 0093-8741 0093-8741-99 UNFINISHED Active or certified unfinished drug listing 2026-08-17
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 28 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 0093-8741-99 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 0093-8741-99 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 0093-8741-99 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 0093-8741-99 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 0093-8741-99 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 0093-8741-99 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 0093-8741-99 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 0093-8741-99 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 0093-8741-99 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 0093-8741-99 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 0093-8741-99 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 0093-8741-99 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 0093-8741-99 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 0093-8741-99 50b4072663b7…eae3003ed65e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A074377-001 MEXILETINE HYDROCHLORIDE MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 A074377-002 MEXILETINE HYDROCHLORIDE MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 A074377-003 MEXILETINE HYDROCHLORIDE MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 126 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A074377-002 MEXILETINE HYDROCHLORIDE 200MG CAPSULE / ORAL AB 1995-05-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A074377-003 MEXILETINE HYDROCHLORIDE 250MG CAPSULE / ORAL AB RS 1995-05-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A074377-001 MEXILETINE HYDROCHLORIDE 150MG CAPSULE / ORAL AB 1995-05-16 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 114 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Mexiletine Hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MEXILETINE HYDROCHLORIDE 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 606D60IS38 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1362706 Internal RxNorm lookup 1362712 Internal RxNorm lookup 1362720 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-8741-01 Mexiletine Hydrochloride 100 in 1 BOTTLE CAPSULE 100 11
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MEXILETINE HYDROCHLORIDE ACTIVE INGREDIENT 606D60IS38 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 MEXILETINE ACTIVE MOIETY 1U511HHV4Z MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 ALCOHOL INACTIVE INGREDIENT 3K9958V90M MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 AMMONIA INACTIVE INGREDIENT 5138Q19F1X MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 D&C RED NO. 28 INACTIVE INGREDIENT 767IP0Y5NH MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 GELATIN INACTIVE INGREDIENT 2G86QN327L MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 SHELLAC INACTIVE INGREDIENT 46N107B71O MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] 6 MEXILETINE HYDROCHLORIDE ACTIVE INGREDIENT 606D60IS38 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 MEXILETINE HYDROCHLORIDE ACTIVE INGREDIENT 606D60IS38 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 MEXILETINE ACTIVE MOIETY 1U511HHV4Z MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 MEXILETINE ACTIVE MOIETY 1U511HHV4Z MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 ALCOHOL INACTIVE INGREDIENT 3K9958V90M MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 ALCOHOL INACTIVE INGREDIENT 3K9958V90M MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 D&C RED NO. 28 INACTIVE INGREDIENT 767IP0Y5NH MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 SHELLAC INACTIVE INGREDIENT 46N107B71O MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 SHELLAC INACTIVE INGREDIENT 46N107B71O MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) CAPSULE [AVKARE, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MEXILETINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-8741 MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA, INC.] 11 Current NDC, Legacy NDC, 1 package rows 20230630_693da40b-26d4-40d6-87d1-158e256f40ab.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0093-8741-01 00093874101 100 CAPSULE in 1 BOTTLE (0093-8741-01) 100 capsule 1995-06-05 0000-00-00 No No Current 0093-8741-99 00093874199 37500 CAPSULE in 1 PAIL (0093-8741-99) 37500 capsule 30-MAR-23 Current